Literature DB >> 21146685

Stages of systemic hypertension and blood pressure as correlates of computed tomography-assessed aortic valve calcium (from the Multi-Ethnic Study of Atherosclerosis).

Jason Linefsky1, Ronit Katz, Matthew Budoff, Jeffrey Probstfield, David Owens, Junichiro Takasu, David Shavelle, Pamela Ouyang, Bruce Psaty, Kevin D O'Brien.   

Abstract

Hypertension has been identified as a risk factor for aortic valve calcium (AVC) but the magnitude of the risk relation with hypertension severity or whether age affects the strength of this risk association has not been studied. The relation of hypertension severity, as defined by Joint National Committee 7 (JNC-7) hypertension stages or blood pressure (BP), to computed tomographically assessed AVC prevalence and severity was examined in 4,274 participants in the Multi-Ethnic Study of Atherosclerosis (MESA) without treated hypertension. Analyses were stratified by age < 65 or ≥ 65 years, were adjusted for common cardiovascular risk factors, and excluded those on antihypertensive medications. In age-stratified adjusted analyses, stage I/II hypertension was associated with prevalent AVC in those <65 but not in those ≥ 65 years of age (odds ratio [OR] 2.31, 95% confidence interval [CI] 1.35 to 3.94, vs 1.33, 0.96 to 1.85, p for interaction = 0.041). Similarly, systolic BP and pulse pressure were more strongly associated with prevalent AVC in those <65 than in those ≥ 65 years of age (OR 1.21, 95% CI 1.08 to 1.35, vs 1.07, 1.01 to 1.14, per 10-mm Hg increase in systolic BP, p for interaction = 0.006; and OR 1.41, 95% CI 1.21 to 1.64, vs 1.14, 1.05 to 1.23, per 10-mm Hg increase in pulse pressure). No associations were found between hypertension stage or BP and AVC severity. In conclusion, stage I/II hypertension and higher systolic BP and pulse pressure were associated with prevalent AVC. These risk associations were strongest in participants < 65 years of age.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21146685      PMCID: PMC3032359          DOI: 10.1016/j.amjcard.2010.08.042

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  27 in total

1.  Usefulness of aortic valve calcium scores by electron beam computed tomography as a marker for aortic stenosis.

Authors:  David M Shavelle; Matthew J Budoff; Nediljka Buljubasic; Audrey H Wu; Junichiro Takasu; Joseph Rosales; Catherine M Otto; Xue Qiao Zhao; Kevin D O'Brien
Journal:  Am J Cardiol       Date:  2003-08-01       Impact factor: 2.778

2.  Evaluation and clinical implications of aortic valve calcification measured by electron-beam computed tomography.

Authors:  David Messika-Zeitoun; Marie-Christine Aubry; Delphine Detaint; Lawrence F Bielak; Patricia A Peyser; Patrick F Sheedy; Stephen T Turner; Jerome F Breen; Christopher Scott; A Jamil Tajik; Maurice Enriquez-Sarano
Journal:  Circulation       Date:  2004-07-12       Impact factor: 29.690

3.  Quantification of coronary artery calcium using ultrafast computed tomography.

Authors:  A S Agatston; W R Janowitz; F J Hildner; N R Zusmer; M Viamonte; R Detrano
Journal:  J Am Coll Cardiol       Date:  1990-03-15       Impact factor: 24.094

4.  Relation of thoracic aortic and aortic valve calcium to coronary artery calcium and risk assessment.

Authors:  Nathan D Wong; Maria Sciammarella; Yadon Arad; Romalisa Miranda-Peats; Donna Polk; Rory Hachamovich; John Friedman; Sean Hayes; Anthony Daniell; Daniel S Berman
Journal:  Am J Cardiol       Date:  2003-10-15       Impact factor: 2.778

5.  Association of cardiovascular risk factors to aortic valve calcification as quantified by electron beam computed tomography.

Authors:  Karsten Pohle; Merle Otte; Ralph Mäffert; Dieter Ropers; Michael Schmid; Werner G Daniel; Stephan Achenbach
Journal:  Mayo Clin Proc       Date:  2004-10       Impact factor: 7.616

6.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  JAMA       Date:  2003-05-14       Impact factor: 56.272

7.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

Authors:  Sarah Lewington; Robert Clarke; Nawab Qizilbash; Richard Peto; Rory Collins
Journal:  Lancet       Date:  2002-12-14       Impact factor: 79.321

8.  Interaction of age with lipoproteins as predictors of aortic valve calcification in the multi-ethnic study of atherosclerosis.

Authors:  David S Owens; Ronit Katz; Eric Johnson; David M Shavelle; Jeffrey L Probstfield; Junichiro Takasu; John R Crouse; J Jeffrey Carr; Richard Kronmal; Matthew J Budoff; Kevin D O'Brien
Journal:  Arch Intern Med       Date:  2008-06-09

9.  Single versus combined blood pressure components and risk for cardiovascular disease: the Framingham Heart Study.

Authors:  Stanley S Franklin; Victor A Lopez; Nathan D Wong; Gary F Mitchell; Martin G Larson; Ramachandran S Vasan; Daniel Levy
Journal:  Circulation       Date:  2008-12-31       Impact factor: 29.690

10.  Multi-Ethnic Study of Atherosclerosis: objectives and design.

Authors:  Diane E Bild; David A Bluemke; Gregory L Burke; Robert Detrano; Ana V Diez Roux; Aaron R Folsom; Philip Greenland; David R Jacob; Richard Kronmal; Kiang Liu; Jennifer Clark Nelson; Daniel O'Leary; Mohammed F Saad; Steven Shea; Moyses Szklo; Russell P Tracy
Journal:  Am J Epidemiol       Date:  2002-11-01       Impact factor: 4.897

View more
  5 in total

Review 1.  Risk factors for valvular calcification.

Authors:  Hao Yu Chen; James C Engert; George Thanassoulis
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2019-04       Impact factor: 3.243

2.  Relation of aortic valve calcium to chronic kidney disease (from the Chronic Renal Insufficiency Cohort Study).

Authors:  Marie A Guerraty; Boyang Chai; Jesse Y Hsu; Akinlolu O Ojo; Yanlin Gao; Wei Yang; Martin G Keane; Matthew J Budoff; Emile R Mohler
Journal:  Am J Cardiol       Date:  2015-02-12       Impact factor: 2.778

Review 3.  Innate immune cells in the pathophysiology of calcific aortic valve disease: lessons to be learned from atherosclerotic cardiovascular disease?

Authors:  Wieteke Broeders; Siroon Bekkering; Saloua El Messaoudi; Leo A B Joosten; Niels van Royen; Niels P Riksen
Journal:  Basic Res Cardiol       Date:  2022-05-17       Impact factor: 12.416

Review 4.  Inflammatory and Biomechanical Drivers of Endothelial-Interstitial Interactions in Calcific Aortic Valve Disease.

Authors:  Katherine Driscoll; Alexander D Cruz; Jonathan T Butcher
Journal:  Circ Res       Date:  2021-04-29       Impact factor: 17.367

5.  Risk Factors for Calcific Aortic Valve Disease in Afghan Population.

Authors:  Abdul Ghafar Sherzad; Muhibullah Shinwari; M Azim Azimee; Arash Nemat; Qingchun Zeng
Journal:  Vasc Health Risk Manag       Date:  2022-08-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.